2004
DOI: 10.1016/j.anireprosci.2004.04.026
|View full text |Cite
|
Sign up to set email alerts
|

Steroidal regulation of uterine immune defenses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
71
0
10

Year Published

2006
2006
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 94 publications
(84 citation statements)
references
References 62 publications
3
71
0
10
Order By: Relevance
“…Sin embargo, es importante mencionar que actualmente no existe un consenso sobre un tratamiento efectivo para la CITO. El uso de PGF2á durante el diestro da como resultado la luteólisis y, posteriormente, el estro, que aumenta la inmunidad local mediante la eliminación del efecto inmunosupresor de la progesterona [95,96]. Además, la PGF2á posee un efecto ecbólico por el cual efectúa la eliminación de bacterias y debris [97]; sin embargo, solo un estudio mostró un beneficio En dos amplios estudios de campo realizados significativo del tratamiento con PGF2á [98], por nuestro grupo de investigación, utilizando el mientras que otros estudios no [38,97].…”
Section: Referenciaunclassified
“…Sin embargo, es importante mencionar que actualmente no existe un consenso sobre un tratamiento efectivo para la CITO. El uso de PGF2á durante el diestro da como resultado la luteólisis y, posteriormente, el estro, que aumenta la inmunidad local mediante la eliminación del efecto inmunosupresor de la progesterona [95,96]. Además, la PGF2á posee un efecto ecbólico por el cual efectúa la eliminación de bacterias y debris [97]; sin embargo, solo un estudio mostró un beneficio En dos amplios estudios de campo realizados significativo del tratamiento con PGF2á [98], por nuestro grupo de investigación, utilizando el mientras que otros estudios no [38,97].…”
Section: Referenciaunclassified
“…Neutrophils, which are involved in the initial attack against bacteria entering the uterus (Targowski 1984, Lewis 2004, attacked the shell-free conceptus, providing the first experimental evidence that the marsupial shell coat provides an immunoprotective barrier between the conceptus and the maternal immune system. Although shell-free conceptuses are able to survive in vitro during cleavage (Moore & Taggart 1993, Renfree & Lewis 1996, Casey & Selwood 2003, the presence of neutrophils attacking the shell-free conceptus in vivo shown here and in vitro conceptus failure during blastocyst formation after shell removal (Casey & Selwood 2003), show that the long-term survival of a conceptus would be compromised in GST-CP4-immunized animals.…”
Section: Uterine Secretions As Immunocontraceptive Targetsmentioning
confidence: 99%
“…However, in eutherians, semen, the conceptus (Robertson 2000), progesterone (Piccinni 2003, Lewis 2004) and in mice, early pregnancy factor (EPF; Morton 1998) induce the expression of specific cytokines able to skew the differentiation and expansion of certain lymphocyte populations, suppressing the immune response. Further immunization during oestrus results in a lower immunoglobulin response than at other times in both rats (Wira & Rossoll 1995) and mice (Gockel et al 2000).…”
Section: Major Histocompatibility Class (Mhc) IImentioning
confidence: 99%
“…Such alterations in ghrelin action could be due to the initial state of ovarian cells affected by season, nutrition and other environmental factors. P 4 , OXT and PGF are known to control of ovarian luteogenesis, uterine contractions and the immune response (Mitchell & Schmid 2001, Lewis 2004, while steroid hormones and IGF1 are known promoters of ovarian follicullogenesis (Hillier 2000, Berisha & Schams 2005. It is possible that ghrelin acting through P 4 , OXT, IGF1, steroids and PGF mediates effect of nutrition on these processes.…”
Section: Effect Of Ghrelin and Stat1 On Ovarian Cellsmentioning
confidence: 99%
“…These observations demonstrate that STAT1 can inhibit ovarian functions, acting as a suppressor of ovarian follicular cell proliferation and, perhaps, of resulting follicular growth, and as a promoter of ovarian cell apoptosis and resulting follicular atresia. Furthermore, STAT1 can stimulate ovarian PGF and OXT, antiluteal and anti-conception factors (Wathes 1989, Mitchell & Schmid 2001, Lewis 2004. Therefore, STAT1 can be considered to be a negative regulator of reproductive processes and mediator of unknown extracellular factors inhibiting these processes.…”
Section: Effect Of Ghrelin and Stat1 On Ovarian Cellsmentioning
confidence: 99%